CL2007003792A1 -
COMPOUNDS DERIVED FROM SUBSTITUTED PIPERIDINS CONTAINING A PORTION OF HETEROARILAMIDE OR HETEROARILFENIL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
- Google Patents
COMPOUNDS DERIVED FROM SUBSTITUTED PIPERIDINS CONTAINING A PORTION OF HETEROARILAMIDE OR HETEROARILFENIL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40261611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003792(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0625682Aexternal-prioritypatent/GB0625682D0/en
Application filed by Astex Therapeutics Ltd CancerfiledCriticalAstex Therapeutics Ltd Cancer
Publication of CL2007003792A1publicationCriticalpatent/CL2007003792A1/en
CL2007003792A2006-12-212007-12-21
COMPOUNDS DERIVED FROM SUBSTITUTED PIPERIDINS CONTAINING A PORTION OF HETEROARILAMIDE OR HETEROARILFENIL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
CL2007003792A1
(en)
COMPOUNDS DERIVED FROM SUBSTITUTED PIPERIDINS CONTAINING A PORTION OF HETEROARILAMIDE OR HETEROARILFENIL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE HEPATITIS C VIRUS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT.
COMPOUNDS DERIVED FROM SULFONAMIDS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER, DYSLIPIDEMIA, DIABETES, OBESITY, INFECTION.
COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS.
COMPOUNDS DERIVED FROM PIRROLO PIRIDINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF THE DISEASE OF ALZHEIMER, PARKINSON, CANCER, AMONG OTHER ILLNESSES.
COMPOUNDS DERIVED FROM SUBSTITUTED FUSED CYCLES; PHARMACEUTICAL AGENT UNDERSTANDING THESE COMPOUNDS; AND USE FOR THE PREVENTION OR TREATMENT OF DIABETES.
COMPOUNDS DERIVED FROM NITROGEN HETEROMONOCYCLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CIRCULATORY DISEASES, METABOLIC DISEASES AND / OR DISEASES OF THE CEN NERVOUS SYSTEM
Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer.
COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
COMPOUNDS DERIVED FROM SUBSTITUTED CONDENSED HETEROCICLES, INHIBITORS OF THE ACTIVITY OF THE AKT; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OR PREVENTION OF CANCER.
COMPOUNDS DERIVED FROM BENZOILAMINO HETEROCICLOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE OF THE COMPOUND IN THE TREATMENT OF TYPE II DIABETES.
COMPOUNDS DERIVED FROM PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF ALLERGIC DISORDERS, AUTOIMMUNES, INFLAMMATORY DISEASES.
Compounds derived from pyrimidin-2-yl-1h-indole, atr protein kinase inhibitors; pharmaceutical composition comprising one of the compounds; and use of the compounds in the preparation of useful medicines for the treatment of cancer.
COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES
COMPOUNDS DERIVED FROM PIRAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.